Literature DB >> 26360697

Toxoplasma Chorioretinitis Subsequent to Anti-tumour Necrosis Factor Alpha Treatment in a Patient with Ankylosing Spondylitis.

I Batmaz1, F Turkçu2.   

Abstract

Entities:  

Year:  2015        PMID： 26360697      PMCID： PMC4696644          DOI： 10.7727/wimj.2014.126

Source DB:  PubMed          Journal:  West Indian Med J        ISSN： 0043-3144            Impact factor:   0.171


× No keyword cloud information.
  4 in total

1.  Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis.

Authors:  Slim Lassoued; Laurent Zabraniecki; Frédéric Marin; Thierry Billey
Journal:  Semin Arthritis Rheum       Date:  2006-10-25       Impact factor: 5.532

2.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

Authors:  J Keane; S Gershon; R P Wise; E Mirabile-Levens; J Kasznica; W D Schwieterman; J N Siegel; M M Braun
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

3.  Which patients with ankylosing spondylitis should be treated with tumour necrosis factor inhibiting therapy? A survey among Dutch rheumatologists.

Authors:  R Landewé; B Rump; D van der Heijde; S van der Linden
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

4.  Outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis.

Authors:  A Linssen; C Meenken
Journal:  Am J Ophthalmol       Date:  1995-09       Impact factor: 5.258
  4 in total
  1 in total

1.  Toxoplasmosis in patients with an autoimmune disease and immunosuppressive agents: A multicenter study and literature review.

Authors:  Marie-Fleur Durieux; Jean-Guillaume Lopez; Maher Banjari; Karine Passebosc-Faure; Marie-Pierre Brenier-Pinchart; Luc Paris; Gilles Gargala; Sabine Berthier; Julie Bonhomme; Cathy Chemla; Isabelle Villena; Pierre Flori; Emilie Fréalle; Coralie L'Ollivier; Florian Lussac-Sorton; José Gilberto Montoya; Estelle Cateau; Christelle Pomares; Loïc Simon; Dorothée Quinio; Florence Robert-Gangneux; Hélène Yera; Marc Labriffe; Anne-Laure Fauchais; Marie-Laure Dardé
Journal:  PLoS Negl Trop Dis       Date:  2022-08-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.